SE7608092L - Nya steroider - Google Patents

Nya steroider

Info

Publication number
SE7608092L
SE7608092L SE7608092A SE7608092A SE7608092L SE 7608092 L SE7608092 L SE 7608092L SE 7608092 A SE7608092 A SE 7608092A SE 7608092 A SE7608092 A SE 7608092A SE 7608092 L SE7608092 L SE 7608092L
Authority
SE
Sweden
Prior art keywords
dehydro
new steroids
androstane derivatives
steroids
new
Prior art date
Application number
SE7608092A
Other languages
Unknown language ( )
English (en)
Inventor
A F Marx
N C M E Barendse
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Publication of SE7608092L publication Critical patent/SE7608092L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/005—3 membered carbocyclic rings in position 12
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/007—3 membered carbocyclic rings in position 6-7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7608092A 1975-07-16 1976-07-15 Nya steroider SE7608092L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB29898/75A GB1550343A (en) 1975-07-16 1975-07-16 Androstane derivatives

Publications (1)

Publication Number Publication Date
SE7608092L true SE7608092L (sv) 1977-01-17

Family

ID=10298992

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7608092A SE7608092L (sv) 1975-07-16 1976-07-15 Nya steroider

Country Status (20)

Country Link
US (1) US4075233A (sv)
JP (1) JPS5212159A (sv)
AT (1) AT362085B (sv)
AU (1) AU506101B2 (sv)
BE (1) BE844169A (sv)
CH (1) CH626379A5 (sv)
DE (1) DE2631915A1 (sv)
DK (1) DK142877B (sv)
FI (1) FI55851C (sv)
FR (1) FR2317934A1 (sv)
GB (1) GB1550343A (sv)
HU (1) HU175369B (sv)
IE (1) IE43693B1 (sv)
IT (1) IT1063150B (sv)
LU (1) LU75394A1 (sv)
NL (1) NL7607824A (sv)
NO (1) NO146865C (sv)
NZ (1) NZ181482A (sv)
SE (1) SE7608092L (sv)
ZA (1) ZA764195B (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1566905A (en) * 1977-03-28 1980-05-08 Gist Brocades Nv Steroids of the a-nor-androstane and a-nor-estrane series
DE3115995A1 (de) * 1981-04-13 1982-11-04 Schering Ag, 1000 Berlin Und 4619 Bergkamen D-homo-4,17-androstadien-3-on, verfahren zu seiner herstellung und diese verbindung enthaltende pharmazeutische praeparate
JPS58185406A (ja) * 1982-04-20 1983-10-29 Mitsubishi Gas Chem Co Inc 過硼酸塩の製造方法
GR80020B (en) * 1983-08-02 1984-12-11 Research Corp Steroids useful as anti-cancer,anti-obesity,anti-hyperglycemic, anti-autoimmune and anti-hypercholesterolemic agents
DE3514272A1 (de) * 1985-04-17 1986-10-23 Schering AG, 1000 Berlin und 4709 Bergkamen Dermatica
US5175154A (en) * 1987-11-25 1992-12-29 Research Corporation Technologies, Inc. 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds
US5001119A (en) * 1987-11-25 1991-03-19 Schwartz Arthur G 16-substituted androstanes and 16-substituted androstenes
US4898694A (en) * 1987-11-25 1990-02-06 Schwartz Arthur G 17-Hydroxy-steroids
US5028631A (en) * 1987-11-25 1991-07-02 Schwartz Arthur G Homoandrostan-17-one and homoandrosten-17-ones
US5883087A (en) * 1991-01-07 1999-03-16 Pherin Corporation Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US5969168A (en) * 1991-01-07 1999-10-19 Pherin Corporation Androstanes for inducing hypothalamic effects
US5925774A (en) * 1991-01-07 1999-07-20 Pherin Corporation Estrenes for inducing hypothalamic effects
EP0711169B1 (en) * 1993-06-15 2003-12-10 Pherin Corporation Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US6117860A (en) * 1994-08-04 2000-09-12 Pherin Pharmaceuticals, Inc. Steroids as neurochemical stimulators of the VNO to treat paroxistic tachycardia
US6066627A (en) * 1994-08-04 2000-05-23 Pherin Corporation Steroids as neurochemical initiators of change in human blood levels of LH
US6331534B1 (en) 1994-08-04 2001-12-18 Pherin Pharmaceuticals, Inc. Steroids as neurochemical stimulators of the VNO to alleviate pain
US6057439A (en) * 1994-08-04 2000-05-02 Pherin Corporation Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety
CN112778390B (zh) * 2021-01-22 2022-09-30 厦门欧瑞捷生物科技有限公司 一种雄烯酮的合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3501462A (en) * 1966-05-02 1970-03-17 Sterling Drug Inc 17-cyclopropyl steroids

Also Published As

Publication number Publication date
FI55851B (fi) 1979-06-29
BE844169A (fr) 1977-01-17
ZA764195B (en) 1977-07-27
FI762058A (sv) 1977-01-17
DK321676A (sv) 1977-01-17
FR2317934B1 (sv) 1980-11-07
FR2317934A1 (fr) 1977-02-11
GB1550343A (en) 1979-08-15
JPS5212159A (en) 1977-01-29
DE2631915A1 (de) 1977-02-03
AT362085B (de) 1981-04-27
DK142877C (sv) 1981-09-28
NO146865C (no) 1982-12-22
NZ181482A (en) 1978-12-18
ATA519776A (de) 1980-09-15
HU175369B (hu) 1980-07-28
IE43693L (en) 1977-01-16
FI55851C (fi) 1979-10-10
NO762483L (sv) 1977-01-18
IT1063150B (it) 1985-02-11
IE43693B1 (en) 1981-05-06
NO146865B (no) 1982-09-13
AU1593876A (en) 1978-01-19
DK142877B (da) 1981-02-16
AU506101B2 (en) 1979-12-13
LU75394A1 (sv) 1977-02-28
US4075233A (en) 1978-02-21
CH626379A5 (sv) 1981-11-13
NL7607824A (nl) 1977-01-18

Similar Documents

Publication Publication Date Title
SE7608092L (sv) Nya steroider
PT97689A (pt) Processo para a preparacao de composicoes farmaceuticas incorporando como ingrediente activo isoxazol-4-carboxilamida e hidroxialquilideno-cianoacetamida
NO154582C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive difenyl-dibutylpiperazinkarboksamider.
NO150361C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-(1h-tetrazol-5-yl)-4h-(pyrido-(1,2-a)-pyrimidin-4-on-derivater
SE444809B (sv) Alfa-skyddade oxiimino-beta-oxo-gamma-halogensmorsyraderivat till anvendning som mellanprodukt for framstellning av farmaceutiskt anvendbara cefemforeningar
NO154918C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
SE7614258L (sv) Forfarande for framstellning av kinazoloderivat
NO156611C (no) Analogifremgangsmaate for fremstilling av terapeutiske virksomme derivater av hydroksykarbonylfosfonsyre.
NO142304C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-acyl-4-oxo-hexahydro-4h-pyrazino-(2,1-a)-isokinolin-derivater
NL7510104A (nl) Werkwijze ter bereiding van een oraal werkzaam farmaceutisch preparaat.
NO142400C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, nye benzimidazolinon-derivater
NL7606120A (nl) Werkwijze voor de bereiding van farmacologisch werkzame heteroarylderivaten.
NL7606178A (nl) Werkwijze voor de bereiding van farmacologisch actieve heteroarylderivaten.
SE7701187L (sv) Nya piperazinderivat och sett att framstella desamma
ES480112A1 (es) Procedimiento para la preparacion de nuevos derivados de 2- iminoimidazolidina.
ZA826453B (en) Tricyclic thiazolyloxamic acids and their derivatives,their preparation,and therapeutic agents containing these compounds
NO140858C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 2,4-diamino-5-benzyl-pyrimidinderivater
SE7909106L (sv) Nya aryltrifluoretanoler, sett att framstella dessa samt deras anvendning som terapeutika
NO784325L (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive tetracyklononanderivater
NO142524C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive cykloheksylfenyl-derivater
OA06135A (fr) Composition pharmaceutique administrable par voie orale.
NO154056C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isopropylamino-pyrimidin-hydroksy-derivater.
PT64998B (fr) Procede de preparation de nouvelles compositions pharmaceutiques et compositions obtenues par ce procede
SE7701504L (sv) Antihypertensiva medel
SE7614537L (sv) Forfarande for framstellning av n?721-(2-tetra - hydrofuryl)-5-fluoruracil

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7608092-8